Physician profile
Sean Patrick Dunn
NPI 1699001776
$287.18
in general payments reported to CMS, 2019-2025
9 companies · $21.85 in 2025
The $21.85 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.36 · 2020: $13.37 · 2022: $114 · 2023: $50.28 · 2024: $37.77 · 2025: $21.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $72.79 | 2022-2023 | V.A.C. Veraflo |
| Stryker Corporation | $71.55 | 2022-2025 | Easyfuse |
| Medline Industries LP | $50.36 | 2019 | |
| Solventum Corporation | $22.93 | 2024 | Activ.A.C. |
| Urgo Medical North America, LLC | $15.77 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Mimedx Group, INC. | $14.84 | 2024 | |
| Aroa Biosurgery Incorporated | $13.37 | 2020 | |
| Tactile Systems Technology INC | $13.31 | 2023 | Flexitouch Plus, Entre Plus |
| Smith+Nephew, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.